Status:
UNKNOWN
Skin Sparing Mastectomy and Immediate Breast Reconstruction With Latissimus Dorsi Flap After Neoadjuvant Chemotherapy and Radiotherapy (M-RIC)
Lead Sponsor:
Clinique Clementville
Conditions:
Breast Carcinoma
Eligibility:
FEMALE
18-75 years
Phase:
PHASE2
Brief Summary
The aim of the study is to evaluate the feasibility and morbidity of skin sparing mastectomy and immediate breast reconstruction with latissimus dorsi flap after neoadjuvant chemotherapy and radiother...
Eligibility Criteria
Inclusion
- Women \< 75 year old
- Invasive breast carcinoma, indication for mastectomy
- Women Health Organization (WHO) score of 0 and 1, primary chemotherapy, external radiotherapy performed less than 8 week earlier...
Exclusion
- Women older than 75
- Metastatic breast carcinoma
- Antecedents of previously treated homolateral breast carcinoma
- Documented cancer progression
- Smoker at the moment of the indication surgery
- Known diabetes, neoadjuvant hormonal treatment...
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2017
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01199354
Start Date
July 1 2010
End Date
July 1 2017
Last Update
June 9 2011
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Polyclinique Urbain V
Avignon, France
2
Polyclinique Urbain V
Avignon, France
3
Centre Jean Perrin
Clermont-Ferrand, France
4
Groupe Hospitalier Mutualiste Clinique les Eaux Claires
Grenoble, France